Viewing Study NCT05516758


Ignite Creation Date: 2025-12-25 @ 12:07 AM
Ignite Modification Date: 2026-06-14 @ 12:47 AM
Study NCT ID: NCT05516758
Status: TERMINATED
Last Update Posted: 2025-12-04
First Post: 2022-08-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis
Sponsor: Eli Lilly and Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis View
None Arthritis View
None Joint Diseases View
None Musculoskeletal Diseases View
None Rheumatic Diseases View
None Connective Tissue Diseases View
None Autoimmune Diseases View
None Immune System Diseases View
Keywords: